Jonathan Rubine, MD
Medical Director at MKR CLINICAL RESEARCH CONSULTANTS, INC.- Claim this Profile
Click to upgrade to our gold package
for the full feature experience.
Topline Score
Bio
Jaclyn Riley Castillo
Jonathan Rubine was employed as a Lead Medical Safety Officer from 2014 to 2016. During his time at Biorasi, he was responsible for safety-related communication with investigator sites, management of adverse events, query management/resolution, case report forms and source documentation consistency, data tracking in safety and clinical databases, and MedDRA and WHO Drug coding. Jonathan fulfilled employment responsibilities with very little supervision. The position required interaction with the study Sponsor, clinical sites, as well as the ability to liaise internally between different departments. His success was dependent on organization, determination, communication, and interpersonal skills. Jonathan worked with me on several projects as a Lead Safety Officer, and based on his work, I would highly recommend him.
Jaclyn Riley Castillo
Jonathan Rubine was employed as a Lead Medical Safety Officer from 2014 to 2016. During his time at Biorasi, he was responsible for safety-related communication with investigator sites, management of adverse events, query management/resolution, case report forms and source documentation consistency, data tracking in safety and clinical databases, and MedDRA and WHO Drug coding. Jonathan fulfilled employment responsibilities with very little supervision. The position required interaction with the study Sponsor, clinical sites, as well as the ability to liaise internally between different departments. His success was dependent on organization, determination, communication, and interpersonal skills. Jonathan worked with me on several projects as a Lead Safety Officer, and based on his work, I would highly recommend him.
Jaclyn Riley Castillo
Jonathan Rubine was employed as a Lead Medical Safety Officer from 2014 to 2016. During his time at Biorasi, he was responsible for safety-related communication with investigator sites, management of adverse events, query management/resolution, case report forms and source documentation consistency, data tracking in safety and clinical databases, and MedDRA and WHO Drug coding. Jonathan fulfilled employment responsibilities with very little supervision. The position required interaction with the study Sponsor, clinical sites, as well as the ability to liaise internally between different departments. His success was dependent on organization, determination, communication, and interpersonal skills. Jonathan worked with me on several projects as a Lead Safety Officer, and based on his work, I would highly recommend him.
Jaclyn Riley Castillo
Jonathan Rubine was employed as a Lead Medical Safety Officer from 2014 to 2016. During his time at Biorasi, he was responsible for safety-related communication with investigator sites, management of adverse events, query management/resolution, case report forms and source documentation consistency, data tracking in safety and clinical databases, and MedDRA and WHO Drug coding. Jonathan fulfilled employment responsibilities with very little supervision. The position required interaction with the study Sponsor, clinical sites, as well as the ability to liaise internally between different departments. His success was dependent on organization, determination, communication, and interpersonal skills. Jonathan worked with me on several projects as a Lead Safety Officer, and based on his work, I would highly recommend him.
Experience
-
MKR CLINICAL RESEARCH CONSULTANTS, INC.
-
United States
-
Research
-
1 - 100 Employee
-
Medical Director
-
May 2019 - Present
-
-
-
WideTrial, Inc.
-
United States
-
Hospitals and Health Care
-
1 - 100 Employee
-
Medical Director
-
Jan 2020 - Jan 2022
OverviewWideTrial creates special clinical trials for large numbers of seriously ill patients who cannot take part in the research trials of new, pre-market medicines. These FDA-authorized clinical trials are called "Expanded Access" trials, commonly known as Expanded Access programs (EAPs).Development-stage drug companies (and device makers) partner with us for turn-key solutions: (1) providing pre-approval treatment access to meaningful numbers of doctors and patients, and (2) generating vast sets of secondary clinical data that may contribute to label claims, inform further research, and lead to real-world insights to the drug's value in the targeted population.WideTrial is not a CRO. It is the world's first company formed as an independent sponsor of Expanded Access trials. It is an early-stage commercial venture that came out of six years of subject-matter leadership in the non-profit sector. Our goal is to make sure every patient has treatment options, not just the few who meet the inclusion criteria of research studies. We meet that goal by making large-size Expanded Access programs feasible for all parties involved.
-
-
-
Catalyst Pharmaceuticals
-
United States
-
Pharmaceutical Manufacturing
-
1 - 100 Employee
-
Associate Medical Director
-
Jan 2016 - May 2019
-
-
-
Biorasi
-
United States
-
Research Services
-
200 - 300 Employee
-
Lead, Medical Safety Officer
-
Sep 2014 - Jan 2016
-
-
-
-
Assistant Clinical Research Associate
-
2007 - 2014
Intermittent employment Intermittent employment
-
-
-
Louis and Anne Green Memory & Wellness Center
-
United States
-
Wellness and Fitness Services
-
1 - 100 Employee
-
Research Assistant
-
2006 - 2007
-
-
-
Florida Atlantic University
-
United States
-
Higher Education
-
700 & Above Employee
-
Teaching Assistant
-
2004 - 2005
-
-
Education
-
2010 - 2014
University of Sint Eustatius School of Medicine
Doctor of Medicine (MD), Medicine -
2004 - 2005
Florida Atlantic University
Master of Science (MS), Biomedical Sciences, General -
2000 - 2004
Penn State University
Bachelor of Science (BS), Nutrition Sciences
Community
